Sreekanth Chaguturu’s Post

View profile for Sreekanth Chaguturu, graphic

Chief Medical Officer at CVS Health

As the U.S. pharmaceutical landscape continues to evolve, biosimilars are one of the biggest opportunities for reducing drug costs for employers and consumers. For the past year, CVS Health has been building a strong team of individuals dedicated to increasing access to quality biosimilars for patients. In collaboration with CVS Health’s Cordavis subsidiary, the launch of Hyrimoz is just one example of the culmination of these efforts. I’m proud of this growing Cordavis team and of their commitment to increasing access to critical medications. 

  • No alternative text description for this image

As the U.S. pharmaceutical landscape continues to evolve, biosimilars are one of the biggest opportunities for reducing drug costs for employers and consumers. Way to go Cardavis Colleagues

Like
Reply
Elly Brtva, MPH, CFRE

Public Health | Project Management | Health Equity Advocate | CHW Ally | Philanthropy Director | Fundraiser | Board Volunteer Recruiter | Mentor | Resource Development | Strategic Relationships | Artist/Ceramicist

2w

Thanks for all your work to keep our world, and those most vulnerable, healthy!

Like
Reply
Dr. Terra Caudill, MD, MS

Board Certified Psychiatrist (14 States) | American Mensa (top 2% IQ) | Textbook Author (632 pages) | Virtual Care/Telepsychiatry Expert (>20,000 online completed appointments)

1w

Exciting times!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics